Home » Newsletters » BioWorld Science

BioWorld Science

May 19, 2022

View Archived Issues

DEPDC1-AS1 as novel biomarker for the early detection and prognosis of gastric cancer

Celgene, Zoetis describe new compounds for treating helminthic infections

New KRAS protein degraders synthesized at BioTheryX

CXCR4-targeting compounds patented by the University of British Columbia, PHSA

TME Therapeutics discovers PIKfyve inhibitors

New YAP1-TEAD interaction inhibitors identified at Vivace Therapeutics

U.S. researchers present preclinical data on KU-596 in X-linked Charcot-Marie-Tooth disease

AFM-28 in combination with allogeneic NK cells as promising therapy for AML and MDS

Novel selective D3R ligands for the treatment of drug addiction

BEAM-301 restores metabolic function in a murine model of GSD-Ia

Almirall and Inserm collaborate to advance treatment options for vitiligo

Double-negative CAR-T cells show the same efficacy without toxicity

AAV5-Id3 gene-transfer approach reduces corneal fibrosis in a rabbit model

New findings help to identify those most at risk for developing severe COVID-19 complications

Tasquinimod designated U.S. orphan drug for myelofibrosis

Luca Science and Kyowa Kirin establish research collaboration for mitochondrial diseases

NIAID award supports work at UCSF QBI and QCRG on pandemic preparedness

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...